Xeomin Cosmetic

Xeomin is a brand name for an injectable medication called incobotulinumtoxinA. It is a type of botulinum toxin type A that is used for various cosmetic and medical purposes. Xeomin is primarily known for its cosmetic applications and is used to reduce the appearance of facial wrinkles and lines, particularly frown lines between the eyebrows (glabellar lines).

  • 20 units $189
  • 40 units $379
  • 60 units with free gold mask $575

Like other botulinum toxin type A products, Xeomin works by temporarily paralyzing or relaxing the muscles that cause wrinkles. It contains a purified form of the botulinum toxin that blocks nerve signals to the targeted muscles, leading to a reduction in muscle activity and smoothing of the overlying skin.

Xeomin is administered through injections directly into the targeted areas by a healthcare professional. The effects of Xeomin are temporary and typically last for several months, after which further treatments are needed to maintain the desired results.

It’s important to note that Xeomin should only be used under the supervision of a qualified healthcare provider. They will assess your individual needs and determine if Xeomin is an appropriate treatment option for you.



What is the difference between Xeomin and Botox?

Xeomin and Botox are both injectable medications that contain botulinum toxin type A and are used for similar purposes. However, there are a few differences between the two:

  • Manufacturing Process – Xeomin and Botox are manufactured by different companies using slightly different processes. Xeomin is produced using a unique purification process that removes accessory proteins, leaving only the botulinum toxin type A. Botox, on the other hand, is produced using a complexing protein during manufacturing.
  • Formulation – Xeomin consists of only the botulinum toxin type A, while Botox contains the botulinum toxin type A along with certain accessory proteins. These accessory proteins in Botox can sometimes trigger an immune response in some individuals, leading to potential resistance or reduced effectiveness over time. Xeomin’s formulation without accessory proteins may reduce the risk of developing resistance.
  • Unit Measurement – The potency of Xeomin and Botox is measured differently. Xeomin uses a unit measurement called “Retylane Units” (RU), while Botox uses “Allergan Units” (AU). The conversion between the two unit measurements is not one-to-one, so the dosages may differ when comparing the two.
  • Onset and Duration – The onset and duration of results can vary slightly between Xeomin and Botox, but the overall effect and duration are similar. Typically, the effects of both treatments become noticeable within a few days to a week, and the results last for several months. However, individual responses may vary.

It’s important to note that the choice between Xeomin and Botox may depend on individual preferences, the recommendations of a healthcare professional, availability in the specific region, and other factors. Consulting with a qualified healthcare provider who can assess your unique situation is crucial in determining the most suitable treatment option for you.